An essential role for tumor necrosis factor in natural killer cell-mediated tumor rejection in the peritoneum
about
Sequential activation of NKT cells and NK cells provides effective innate immunotherapy of cancer.NK cells in the tumor microenvironment.Granzyme A and B-deficient killer lymphocytes are defective in eliciting DNA fragmentation but retain potent in vivo anti-tumor capacity.NK cells and apoptosis.Unlinking tumor necrosis factor biology from the major histocompatibility complex: lessons from human genetics and animal modelsInnate lymphoid cells facilitate NK cell development through a lymphotoxin-mediated stromal microenvironmentNK cell-based immunotherapy for malignant diseases.IL-23 suppresses innate immune response independently of IL-17A during carcinogenesis and metastasis.Impact of partial versus whole breast radiation therapy on fatigue, perceived stress, quality of life and natural killer cell activity in women with breast cancerGlucocorticoid dysregulation of natural killer cell function through epigenetic modificationRole of TNF family ligands in antitumor activity of natural killer cells.Epigenetic patterns associated with the immune dysregulation that accompanies psychosocial distressNew aspects of natural-killer-cell surveillance and therapy of cancer.CD160 is essential for NK-mediated IFN-γ productionNK cells require IL-28R for optimal in vivo activityResident peritoneal NK cells.Cytokines in cancer immunity and immunotherapy.Antigen-specific tumor vaccine efficacy in vivo against prostate cancer with low class I MHC requires competent class II MHC.Enhanced antitumor immunity in mice deficient in CD69.Suppression of lymphoma and epithelial malignancies effected by interferon gammam144, a murine cytomegalovirus (MCMV)-encoded major histocompatibility complex class I homologue, confers tumor resistance to natural killer cell-mediated rejection.Differential tumor surveillance by natural killer (NK) and NKT cells.Childhood adversity increases vulnerability for behavioral symptoms and immune dysregulation in women with breast cancer.Innate immune surveillance of spontaneous B cell lymphomas by natural killer cells and gammadelta T cells.Suppression of tumor formation in lymph nodes by L-selectin-mediated natural killer cell recruitmentFunctional subsets of mouse natural killer cells.Effect of mindfulness based stress reduction on immune function, quality of life and coping in women newly diagnosed with early stage breast cancer.Dissecting the role of hyperthermia in natural killer cell mediated anti-tumor responses.p110gamma and p110delta isoforms of phosphoinositide 3-kinase differentially regulate natural killer cell migration in health and diseaseA flagellin-derived toll-like receptor 5 agonist stimulates cytotoxic lymphocyte-mediated tumor immunityA critical analysis of the tumour immunosurveillance controversy for 3-MCA-induced sarcomas.Role of TNF superfamily ligands in innate immunity.TLR-Stimulated Eosinophils Mediate Recruitment and Activation of NK Cells In Vivo.Targeting cytokine signaling checkpoint CIS activates NK cells to protect from tumor initiation and metastasis.Plasmacytoid dendritic cell-induced migration and activation of NK cells in vivo.NK cells promote peritoneal xenograft rejection through an IFN-gamma-dependent mechanism.Langerhans cells and NK cells cooperate in the inhibition of chemical skin carcinogenesis.Use of porcine tumor necrosis factor receptor 1-Ig fusion protein to prolong xenograft survival.Recruitment and activation of natural killer (NK) cells in vivo determined by the target cell phenotype. An adaptive component of NK cell-mediated responses.A model for cancer-suppressive inflammation
P2860
Q25256900-724DDE3B-9E2D-401B-9725-4249B0307737Q27692606-6F1A521D-AD30-49A4-B367-17C507280095Q31909336-4BF93E52-8294-4574-9C7E-0A21C10F3938Q33547794-526425F0-4342-4607-AFB5-8E82552561FBQ33693892-184C7DD8-6F12-4539-9CC4-34C8F2916E1CQ33826833-FDA5B1EA-EE9F-4C80-8453-8E51758545A3Q33827433-A7AB110E-03E2-4B15-830B-AA7A0D2D8551Q33929197-42809D9C-BDC7-42DF-A671-54559565BAE8Q34307724-7967F682-B093-4E61-AAE3-8DEDB31B4F8EQ34338570-C3F395ED-8164-4F2E-9771-75093C19B3EAQ34552156-EBFB187F-998B-4D36-913B-4101096D92ABQ34819298-4D9934A7-A782-4060-88DA-9F4C1C8D8E99Q34988265-A4B21C44-936B-4A65-BF1C-25F23B543980Q35161483-543C47A6-0CF7-4222-85CD-2082EEE16FB9Q35590214-0C885EF8-4AA5-4E5F-BAAC-A0F9D1AEB0ABQ35613087-DE66548D-2059-410B-9174-1FF2614454C9Q35951855-17D6116B-1878-4D62-854F-D24917D06228Q36093442-57331EBF-6118-443A-810D-F810FAD73F31Q36370985-0E79C152-34C0-4BB6-B30C-2E1D20F91E36Q36371115-DA0F9ED4-74F2-4AC6-8E11-7E4A706D2031Q36375162-3F971A58-2D9F-4711-876B-C37293F5CCD3Q36375962-44E69CD4-097D-41BC-A655-1391BD5DD198Q36381383-596CA70D-4EDA-4CD3-90CA-4318E2BF96ADQ36402321-2A0876E9-4CE5-4286-8796-7060061C24E3Q36403058-1257764F-7176-47D3-A672-76AE2406B12DQ36652157-3545B888-E45A-4D14-993E-A73C6B1CFF89Q36980551-FFF71BEE-5692-4634-A734-FB3FD5B5F252Q37063492-82CDAF70-8F80-4BE9-8F13-422A737CD42DQ37153666-63F1B1B7-3B6F-43C7-8778-1E1B29A10565Q37478775-D445920B-67AB-468F-A40C-A4E1111DDDDAQ37565031-10432406-C6EE-4018-9F23-E2A24A01865AQ37895960-4E8F7F4B-BCC9-4091-85E3-66AD657A97C7Q38706784-076A823D-142F-4BD5-A8B9-E2CC483DFC20Q38875021-EE1FBCFC-77C6-4623-92F0-D9D3110C0714Q39694388-B1DF5379-406E-4FBB-974A-9F33B5D3DC95Q40216612-031D3367-1F6A-41D2-AB8A-55F4624CA1EEQ40277855-A4F0FCA4-019C-4B78-A01C-896A4AAB03D6Q40505143-3196A44A-6A47-4BC3-A3D1-66AA187543A7Q40908512-67C3822A-1C9A-493D-B9B6-D257EAD2BDCDQ41275639-01150821-D605-4538-B60C-E1F59D5A8BE0
P2860
An essential role for tumor necrosis factor in natural killer cell-mediated tumor rejection in the peritoneum
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
An essential role for tumor ne ...... or rejection in the peritoneum
@ast
An essential role for tumor ne ...... or rejection in the peritoneum
@en
type
label
An essential role for tumor ne ...... or rejection in the peritoneum
@ast
An essential role for tumor ne ...... or rejection in the peritoneum
@en
prefLabel
An essential role for tumor ne ...... or rejection in the peritoneum
@ast
An essential role for tumor ne ...... or rejection in the peritoneum
@en
P2093
P2860
P356
P1476
An essential role for tumor ne ...... or rejection in the peritoneum
@en
P2093
A G Baxter
J D Sedgwick
P2860
P304
P356
10.1084/JEM.188.9.1611
P407
P577
1998-11-01T00:00:00Z